We deliver a full spectrum of clinical research, market access, and regulatory consulting services from bench to commercialization in Colombia and the rest of Latin America.
Antonio J. Trujillo, PhD
Dr. Trujillo, is currently an associate professor, at the Health Systems Program, Department of International Health, Johns Hopkins Bloomberg School of Public Health. He is an economist from the Catholic University in Caracas, Venezuela, holds a Masters in Public Policy from Columbia University in New York, and a PhD from the University of North Carolina, Chapel Hill. Dr. Trujillo has been a consultant for the Inter-American Development Bank, and the World Bank, among other projects. Dr. Trujillo has has won significant honors, awards, and research grants, has published 48 peer-reviewed journals articles, seven book chapters and reports, and has been an international speaker in over 35 events.
Dr. Trujillo is the director of the Master of Health Science (MHS) in Health Economics degree program at Johns Hopkins Bloomberg School of Public Health. He teaches an advanced econometrics course on program impact evaluation using observational data and a course on behavioral economics and public health.
Juan J. Muñoz
Juan is an experienced international life sciences and healthcare business development, sales, marketing, and management executive. Juan had leadership positions at Baxter Laboratories and Boston Scientific creating, managing, and leading profitable sales operations in Colombia, Venezuela, Ecuador and Peru. Juan is an expert at formulating market access strategies that allow foreign Medtech companies successfully penetrate the challenging Latin American market. Juan has a B.S. in microbiology from Javeriana University and an M.B.A. degree from ICESI; both leading universities in Bogota, Colombia. See Juan's resume here.
Carlos has worked opening new market for several globally-renowned companies such as Cadbury Schweppes, Proctor & Gamble, Walmart, and Omron Healthcare, among others. From 2008 to 2018 Carlos was the Latin American & Caribbean Senior Business Development & Sales Manager for Omron Healthcare —a global manufacturer of consumer home health monitoring equipment with $7B in annual sales.
While at Omron, he tripled sales in the region to over $11M, developed sales and marketing strategies to expand Omron products from specialty to consumer products; and lead the consumer, channel, pricing, competitive positioning and marketing plans for all product categories. He also lead the expansion of Omron products into new channels and new countries, created innovative marketing strategies, supported the regulatory registration process across all markets, and trained and continuously lead Omron's regional sales team to surpass Omron’s sales goals. Carlos was honored with three Omron awards and two trade association awards for workplace excellence. Carlos is based in the Miami, FL area and has a Bachelor of Arts in finance and international business from Florida International University.
Alfredo J. Spath., MD
Dr. Spath. has been part of several medical and scientific activities that involved external stakeholders (e.g., regulatory authorities, key opinion leaders, CROs, advisory boards, patient advocacy groups, etc.), internal stakeholders (i.e., clinical research, translational medicine, global medical affairs, marketing, health economics and outcomes research), and internal decision committees.
Dr. Spath. has led several market access and health economics and outcomes research (HEOR) projects in Spain, Portugal, Central America, the Caribbean, and other countries in Latin America. His work has been instrumental for Pfizer, Jazz, and Novartis, to reach exponential sales growth for drugs to treat solid tumors (breast, lung, renal and gastrointestinal cancer), and Leukemia.
Dr. Spath. is physician, surgeon, internal medicine specialist, and has broad clinical experience in the treatment of cancer patients. He has an MBA from Instituto de Empresa in Madrid, Spain and has over fifteen years of experience in the biopharmaceutical Industry. His main expertise is in oncology and hematology drugs, as well as internal medicine products from companies like Pfizer Novartis and Jazz Pharmaceuticals. He has been the medical leader of critical projects related to medical and regulatory affairs, market access, health economics, clinical research, and core medical strategies for complex and hyper-competitive markets such as Spain, Portugal, Central America, Colombia, and other countries in the Caribbean.
Rodrigo Cervantes, MD
Dr. Cervantes is an accomplished physician who graduated from Mexico's Universidad Autónoma de Guadalajara in 2006. He has occupied leadership positions at top global companies including Novartis, Pfizer, and Janssen, and he has been involved in the formulation and implementation of effective regulatory, scientific, clinical research, and nationwide market access strategies for a vast number of medical products in different therapeutic areas. Throughout his diverse professional experience, Dr. Cervantes has developed a large network of contacts including researchers, key opinion leaders, influencers, buyers, distributors, and regulatory officials, among others. He has worked as consultant for several foreign companies in Mexico; he has successfully launched products, operationalized clinical trials, expanded market share, developed distribution and commercialization networks, and has obtained regulatory approvals for several products. He specializes in conducting market research and formulating winning market access plans with strategic solutions tailored to the demands of the challenging Mexican healthcare environment.